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Abstract 
Background: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals 
display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. 
MicroRNAs (miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. 
Several research studies have indicated that miRNA played an important role in sensitizing cells to ionizing radiation 
(IR). MiR-106b, a member of the miR-106b-25 cluster, is frequently dysregulated in many human cancers, including 
CRC. However, the function of miR-106b in radioresistance is currently poorly understood.
Methods: A series of in vitro and in vivo studies were performed to investigate the roles of miR-106b on cell radiore-
sistance in CRC.
Results: We found overexpression of miR-106b could induce resistance to IR in vitro and in vivo in SW620 cells. Corre-
spondingly, knocking down miR-106b in SW480 yielded the opposite effect. In addition, overexpression of miR-106b 
could enhance the tumour-initiating cell capacity without or with IR condition, such as the colony sphere formation 
capacity and the upregulation of stemness-related genes (CD133, Sox2). We further identified PTEN and p21 as novel 
direct targets of miR-106b by using target prediction algorithms and a luciferase assay. Overexpression of miR-106b 
reduced the expression of PTEN and p21 and increased the expression of p-AKT, which is a downstream of PTEN. 
Restoring the expression of PTEN or p21 in stably miR-106b-overexpressed cells could rescue the effect of miR-106b 
on cell radioresistance. Together, the acquisition of tumour-initiating cell capacity endowed CRC cells with the poten-
tial of resistance to irradiation.
Conclusions: These observations illustrated that miR-106b could induce cell radioresistance by directly targeting 
PTEN and p21, this process was accompanied by tumour-initiating cell capacity enhancement, which is universally 
confirmed to be associated with radioresistance. Our data suggested that miR-106b at least partly induces cell radi-
oresistance in CRC.
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Background
Colorectal cancer (CRC) is one of the most common 
human malignant tumours worldwide. Surgery is the 
main treatment for patients with colorectal cancer. After 
radical surgery, approximately 50% CRC cases experience 
recurrence and metastasis. CRC, specifically rectal can-
cer, frequently presents at a locally advanced stage. A 
short-term regimen of high-dose preoperative radio-
therapy reduces the rate of local recurrence and improves 
survival among patients with resectable rectal cancer [1]. 
Thus, increasing attention should be paid to pre-opera-
tive radiotherapy. However, the therapeutic response 
to preoperative radiotherapy differs among patients 
[2]. Non-responders, who minimally benefit from 
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preoperative radiotherapy, only suffered toxic effects and 
perhaps missed the best treatment opportunity, which 
suggests that promoting the sensitivity of CRC to radio-
therapy is essential.
MicroRNAs are a family of small noncoding RNAs 
that regulate gene expression via special sites within the 
3-untranslated Regions (3′UTR) of target-mRNAs [3–
6]. Mounting evidence suggests that miRNAs affect the 
pathogenesis classification, diagnosis, prognosis and pro-
gression of cancer [7, 8].
MiRNAs have also been implicated in the radiother-
apy response of some tumours. Lin28-let7 modulates 
the radiosensitivity of human cancer cells via the activa-
tion of K-Ras [9]. miR-9 and let-7g could enhance the 
sensitivity to ionizing radiation by suppressing NFkap-
paB1 [10]. MicroRNA-181a sensitizes human malignant 
glioma U87MG cells to radiation by targeting Bcl-2 [11]. 
Up-regulating miR-101 efficiently reduced the protein 
levels of DNA-PKcs and ATM in these tumour cells and 
most importantly, sensitized the tumour cells to radiation 
in vitro and in vivo by targeting DNA-PKcs and ATM [12].
Tumour-initiating cells have been proposed to be 
responsible for the resistance to radiation, as already evi-
denced in cancer [13, 14]. MiR-106b, as a member of the 
miR-106b-25 cluster, is known to promote cancer cell 
proliferation and survival in gastric cancer and hepato-
cellular carcinoma [15–17]. Brett et  al. found that miR-
106b~25 regulates neural stem/progenitor cells (NSPC) 
via the insulin/IGF-FoxO pathway, which may have 
important implications in the homeostasis of the neu-
ral stem cell (NSC) pool during aging [18]. However, the 
relationship between miR-106b, stemness and radiore-
sistance has not yet been elucidated.
A series of in  vitro and in  vivo studies demonstrated 
that the ectopic expression of miR-106b could pro-
mote cell proliferation and tumour growth, enhance the 
tumour-initiating cell capacity and induce cell resistance 
to ionizing radiation in colorectal cancer. The results 
revealed the novel roles of miR-106b in colorectal cancer 
and suggested that miR-106b may be a candidate for the 
treatment of patients with CRC.
Methods
Clinical specimens
Colorectal cancer tissues were collected from fresh sur-
gical specimens, frozen in liquid nitrogen, and stored at 
−80°C until further analysis. All tissues had been histo-
logically confirmed to be adenocarcinoma. Pathologic 
verification and classification were performed based on 
the system of the International Union Against Cancer. 
The research protocol was approved by the Ethics Com-
mittee at Nanfang Hospital, and written consent was 
obtained from all patients for the use of their tissues.
Cell culture
Human colonic carcinoma cell lines HT29, SW480, 
SW620 and LOVO were obtained from American Type 
Culture Collection (ATCC). The CRC cell lines were 
cultured in RPMI-1640 medium (Gibco, USA) sup-
plemented with 10% fetal bovine serum (FBS; Gibco, 
USA), 100 IU/ml penicillin and 100 g/ml streptomycin in 
humidified 5% CO2 at 37°C.
RNA isolation, reverse transcription, and qRT‑PCR
The total RNA was extracted from CRC cell lines with 
RNAiso Plus (Takara, Japan). To detect miR-106b, a stem-
loop reverse transcription-polymerase chain reaction 
(RT-PCR) was performed using All-in-One TM miRNA 
quantitative RT-PCR (qRT-PCR). The sequence-specific 
forward primers for mature miR-106b and the U6 inter-
nal control were 5-TGTAAAGTGCTGACAGTGCA-3 
and 5-CTCGCTTCGGCAGCACA-3, respectively. The 
relative expression was calculated via the comparative 
cycle threshold (Ct) method using the expression of U6 
small nuclear RNA as the reference. The qRT-PCR for the 
analysis of mRNA expression was performed on a Strata-
gene ABI PRISM7500 Fast Real-time PCR system using 
the SYBR Green qRT-PCR master mix (TaKaRa) and 
GAPDH as an internal control. The primers are listed in 
Additional file 1: Table S1. All Data were processed using 
the 2−△△CT method.
MicroRNA mimics, siRNA transient transfection
MicroRNA-106b mimics (sense 5′-UAAAGUGCUGAC 
AGUACAGUGCAGAU-3′ and anti-sense 5′-AUUU 
CACGACUGUCACGACUA-3′), miR-106b inhibitor 
(5′-AUUUCACGACUGUCACGACUA-3′), the nega-
tive control (5′-CAGUACUUUGUGUAGUACAA-3′), 
PTEN-shRNA (sense 5′-GAGCGUGCAGAUAAUGAC 
AdTdA-3′ and anti-sense 3′-dAdT CUCGCACGUCU 
AUUACUGU-5′) and p21-shRNA (sense 5′-GAAAUA 
AACGGGACUGAAA dTdT-3′ and anti-sense 3′-dTdTC 
UUUAUUUGCCCUGACUUU-5′) were purchased from 
GenePharma (Shanghai, China). The transfection was 
performed using Lipofectamine™ 2000 (Invitrogen, USA) 
according to the instructions provided by the manufac-
turer. Twenty-four or 48  h after transfection, the cells 
were harvested for further experiments.
Construction of plasmid vectors and transfection
The coding region of PTEN and p21 was PCR-amplified 
from human genomic DNA using primer pairs (PTEN 
primers forward, 5′-aaggatccCCAGACATGACAGCCA 
TCATC-3′ and reverse 5′-cacaactcgagTCAGACTTTTGT 
AATTTGTGTATGC-3′ and p21 primers forward, 5′-aagg 
atccG G CG CC ATGTC AGAACCG G C TG G G GAT 
GT-3′ and reverse 5′-cacaactcgagTTAGGGCTTCCTCT 
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TGGAGAAGATCAG-3′), digested with BamHI and 
XhoI and ligated to the pcDNA3.1 vector (Additional 
file  2). The transfection was performed using Lipo-
fectamine™2000 (Invitrogen, USA) according to the 
instructions provided by the manufacturer.
Viral vectors
The Viral vectors were purchased from GENECHEM 
company, Shanghai, China (Additional file 3).
Dual‑luciferase reporter assay
The sequences of 3′UTR PTEN and were PCR-amplified 
from human genomic DNA using primer pairs (PTEN 
primers forward, 5′-cacaactcgagTGGCAATAGGACATT 
GTGTCA-3′ and reverse 5′-aaggatccAACAACAAGC 
AGTGACAGCG-3′ and p21 primers forward, 5′-cacaa-
gtcgacTCCGCCCACAGGAAGCCTGCAGTCC-3′ and 
reverse 5′-aaggatccTTACAAGTAAAGTCACTAAGAAT 
CA-3′), digested with BamHI and XhoI and ligated to the 
pLuc vector. They were then cloned downstream of the 
Firefly luciferase stop codon in the pLuc control vector 
(Promega). All constructs were verified by DNA sequenc-
ing (Additional file 4). Cells were seeded in 48-well plates. 
After 24  h of incubation, the cells were co-transfected 
with 1  mg of 3′UTR-PTEN or with 3′UTR mut-PTEN 
combined with the control oligonucleotide (final concen-
tration of 80 nM), mimics (80 nM) or inhibitor (80 nM) 
using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol. Forty-eight hours after transfec-
tion, the Luciferase activity was measured using the Dual 
Luciferase Reporter Assay System (Promega). All trans-
fection experiments were conducted in triplicate and 
repeated independently 3 times.
MTT assay
The viable cell numbers were measured with a 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. The cells were plated in 96-well 
plates and incubated. Twenty microlitres of 5  mg/mL 
MTT (Sigma, USA) was added to each correspond-
ing test well, and the mixture was incubated for 2 h in a 
37°C incubator. The supernatant was then discarded, and 
100 μl of DMSO (dimethyl sulphoxide) was added to each 
well to dissolve the formazan. The optical density (OD) 
was evaluated by measuring the absorbance at 450 nm of 
each well, which was read on a spectrophotometer.
Survival foci formation assay
A predetermined number of cells were seeded in 6-well 
culture plates, and the cells were then incubated for 24 h 
to allow settling. The cells were treated with a range of 
IR doses [0, 2, 4, 6 and 8 Gy, Nasatron (Cs-137) irradia-
tor]. After incubation at 37°C for 14 days, the cells were 
washed twice with PBS and stained with Giemsa solu-
tion. The number of colonies that contained ≥50 cells 
was counted under a microscope using the following for-
mula: plate clone formation efficiency = (number of col-
onies/number of cells inoculated) ×  100%. The survival 
fractions (SF) were calculated by normalizing the data to 
the plating efficiency of appropriate control groups. We 
used GraphPad Prism (GraphPad Software, LaJolla, CA, 
USA) to fit the cell survival curve in accordance with a 
standard linear-quadratic (LQ) model and obtain the val-
ues of the survival fraction of a range of IR doses.
Flow cytometric analysis of apoptosis
One million cells were harvested and washed twice with 
cold PBS, fixed in ice-cold 70% ethanol, and incubated 
overnight at −20°C. The cells were then stained with 
40 μg/ml of propidiumiodide (PI) for 30  min. The cells 
were collected and analysed with the Cell Quest software 
(Becton–Dickinson Co, NJ, USA). The percentage of cells 
with apoptotic nuclei (% apoptosis) was calculated. Each 
experiment was performed in triplicate.
Cell‑cycle analysis
The cells were harvested, washed twice with cold PBS 
and fixed overnight at 4°C in 70% ethanol. After the cells 
were washed twice with PBS, their DNA was stained with 
the Cell Cycle Detection Kit (KeyGen, Nanjin, China). 
The samples were quantified by flow cytometry (Becton–
Dickinson, NJ, USA) and results were analysed with the 
Modfit LT software (Verity Software House, Topsham, 
ME, USA) according to the manufacturer’s instructions.
Tumour sphere formation assay
The cells were digested with 0.25% trypsin (Sigma, 
St. Louis, MO, USA), washed twice with calcium/
magnesium-free PBS, suspended in sphere formation 
medium (DMEM-F12 50  ml +  100  g/ml EGF +  100  g/
ml bFGF +  B27 supplement 1  ml), and seeded in 6-cm 
or 6-well plates (3,000 cells/ml). The cells were cultivated 
for 5–7 days (depending on the cell type), and the spheres 
were then counted under a microscope.
Immunofluorescence
The cells were seeded on cover slips overnight, fixed 
with 4% paraformaldehyde for 30  min and treated with 
0.25% Triton X-100 for 15  min. After blocking in 10% 
normal blocking serum at room temperature for 10 min, 
the slides were incubated with antibodies at 4°C over-
night followed by washing with PBS three times. The 
cover slips were then incubated with Texas Red (TR)-
conjugated antibodies for 30  min at room temperature, 
followed by staining with 6-diamidino-2-phenylindole 
(DAPI; Invitrogen).
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Protein isolation and western blotting
The cells were washed twice with cold phosphate-buff-
ered saline (PBS) and lysed on ice in RIPA buffer with 1% 
PMSF (KeyGen, Nanjin, China). The protein lysates were 
resolved on 10% SDS polyacrylamide gels, transferred to 
PVDF membranes and blocked in 0.1% Tween20 and 5% 
skim milk protein in Tris-buffered saline. The membrane 
was incubated with primary antibodies (E-cadherin, 
Vimentin, CD133, Sox2, p21, PTEN, AKT, p-AKT and 
γ-H2AX purchased from Epitomics company) followed 
by incubation with HRP-labelled rabbit IgG, and the pro-
teins were detected via chemiluminescence. The mem-
brane was then washed and visualized with horseradish 
peroxidase (HRP)-conjugated secondary antibodies for 
1 h. The signals were detected with enhanced chemilumi-
nescence (KeyGen, Nanjin, China).
In vivo tumour growth and xenograft tumour 
radiosensitivity assay
Athymic nude mice aged 4–6  weeks (GuangDong 
Experimental Animal Centre) were used for tumour 
implantation. All animal experiments strictly adhered 
to the Regulations for the Administration of Affairs 
Concerning Experimental Animals outlined in the Chi-
nese national guideline for animal experiments issued 
in 1988. All procedures that involved animals and their 
care in this study were approved and performed by the 
Southern Medical University Institutional Animal Care 
and Use Committee (Permit Number: 44007200000784). 
The cells were harvested by trypsinisation, washed twice 
with cold serum-free medium, and re-suspended with 
200  μl serum-free medium. For the xenograft tumour 
assay, 2 × 106 cells were subcutaneously injected into the 
backs of nude mice. After tumours were detected, the 
tumour size was measured with a slide calliper, and the 
tumour volume was determined with the following for-
mula: 1/2 × length × width2. Each group consisted of six 
athymic nude mice, and the mean tumour volume ± SD 
of each group was calculated. The harvested tumours 
were imaged immediately after sacrifice. To evaluate 
tumour radioresistance in  vivo, the mice were exposed 
to 8  Gy X-rays when the tumours reached an average 
volume of approximately 200  mm3. The tumour inhibi-
tion rate was recorded and calculated every 4 days: Inhi-
bition rate  =  (1  −  irradiation treatment group/control 
group) × 100%.
Immunohistochemistry
After deparaffinisation and rehydration, the slides were 
incubated with 3% hydrogen peroxide solution for 
10  min. After a washing procedure with the supplied 
buffer, the tissue sections were repaired for 40 min with 
ethylenediamine tetraacetic acid. The slides were again 
incubated with the primary antibody overnight at 4°C. 
The primary polyclonal rabbit antibody (Bcl-2 and Bax, 
Bioword) was diluted at 1:100. The slides were then incu-
bated with the secondary antibodies (anti-rabbit, Dako-
Cytomation). The tissue staining was visualized with 
DAB (DakoCytomation). The slides were counterstained 
with haematoxylin and dehydrated. Phosphate buffered 
solution (PBS) was used as the primary antibody for the 
negative controls. Two pathologists each reviewed the 
results of immunostaining.
Statistical analysis
Student’s t test and one-way ANOVA analysis were per-
formed to assess statistical significance. Spearman’s cor-
relation coefficient was calculated to test the association 
between miR-106b and PTEN in the classes normal ver-
sus tumour. The results of all experiments are expressed 
as the mean ±  standard deviation SD of 3 independent 
experiments. P values<0.05 were considered statistically 
significant.
Results
MiR‑106b induces CRC cell resistance to irradiation
First, we analysed the expression pattern of miR-106b in 
CRC cell lines with different degrees of differentiation, 
including LOVO (undifferentiated), HT-29 (highly dif-
ferentiated), SW620 (poorly differentiated), and SW480 
(highly differentiated) cells. We found that the expres-
sion of miR-106b was higher in the highly differentiated 
cells lines HT-29 and SW480 (Additional file  5: Fig-
ure  S1A). Cell lines that stably overexpressed miR-106b 
or expressed reduced amounts of miR-106b were estab-
lished via lentiviral transduction, and this procedure is 
shown in Additional file  5: Figure  S1B (*p<0.05). MTT 
assays were carried out to evaluate the radiosensitiv-
ity when cells were exposed to X-rays at a dose of 4 Gy. 
The data indicated that miR-106b could enhance the 
cell radioresistance (*p<0.05 **p<0.01; Fig.  1a). The col-
ony survival assay is considered a canonical standard to 
determine radiosensitivity. Thus, we sought to explore 
the effect of miR-106b on the colony survival of CRC cells 
in the presence of ionizing radiation. The cells were irra-
diated with various doses of X-rays (0, 2, 4, 6 and 8 Gy), 
and colony formation assays were performed to evaluate 
the survival fraction. The clonogenic assay results con-
firmed that cells that overexpressed miR-160b were more 
resistant to IR than their counterparts, while miR-106b 
knockdown could enhance cell radiosensitivity (*p<0.05; 
Fig. 1b).
Ionizing radiation (IR) could trigger pro-apoptotic sig-
nals in cells with DNA damage, and the phosphorylation 
of histone H2AX (γ-H2AX) is an indicator of the cellular 
response to DNA damage [19, 20]. Immunofluorescence 
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Fig. 1 MiR-106b enhances the cell radioresistance. a The detection of cell sensitivity to irradiation by MTT after miR-106b overexpression or down-
regulation. Data shown are the mean and SE from three independent experiments.*p<0.05 **p<0.01. b Impact of miR-106b on cell survival foci 
formation when exposed to irradiation (2, 4, 6, 8 Gy). The cell survival curve of the clonogenic assay was obtained using the L-Q Linearity Quadri-
model.*p<0.05. c Effect of miR-106b on DNA damage detected by immunofluorescence when exposed to radiation (4 Gy, 6 h). The γ-H2AX staining 
is shown in the left panels and the numbers of γ-H2AX foci are shown in the right panels.*p<0.05. d γ-H2AX and caspase-3 were examined by western 
blot when cells were exposed to radiation (4 Gy, 48 h). e Effects of miR-106b on the xenograft radiosensitivity. Tumour sizes were measured at differ-
ent time points until the mice were sacrificed. The tumour inhibition ratio was calculated every 4 days after exposure to radiation (8 Gy). **p<0.01.
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staining suggested that the overexpression or down-
regulation of miR-106b could decrease or increase 
the γ-H2AX foci numbers, respectively, compared to 
the control groups (*p<0.05; Fig.  1c). The expression 
of γ-H2AX was further verified with a western blot 
(Fig.  1d). We also showed a similar result in the HT29 
cells (Additional file 5: Figure S1C); however, the up-reg-
ulation of miR-106b did not produce significant changes 
in LOVO cells (data not shown). Overall, our findings 
documented that cells that expressed more miR-106b 
were more likely to be radioresistant and repair DNA 
damage.
In addition, we used western blots to analyse the 
expression of apoptosis-related genes in cells in response 
to irradiation. We observed that miR-106b treatment 
alone can decrease the expression of caspase-3, and this 
effect was much stronger when combined with radiation 
therapy (dose of X-ray 4 Gy); reducing miR-106b expres-
sion yielded the converse result (Fig. 1d). Apoptosis was 
assessed with flow cytometry, which showed a similar 
result (**P<0.01; Additional file  5: Figure  S1D). Taken 
together, these observations illustrated a synergistic 
effect between miR-106b restoration and IR.
Finally, xenograft tumours of nude mice were utilized 
to study the sensitivity to IR. Tumour areas (dose of X-ray 
8  Gy) were irradiated when the tumour size reached 
approximately 200  mm3. The tumour size was recorded 
every 4 days after irradiation. The results suggested that 
the overexpression or knockdown of miR-106b could, 
respectively, enhance or reduce tumour radioresistance 
in  vivo, as demonstrated by a lower or higher tumour 
inhibition ratio, respectively, compared with the control 
groups, while down-regulation resulted in an evidently 
higher ratio (**p<0.01; Fig. 1e and Additional file 5: Fig-
ure S1E). We further detected the expression of Bcl-2 and 
Bax in xenograft tumours by immunohistochemistry and 
found that miR-106b could upregulate the expression of 
Bcl-2, while it significantly downregulated the expression 
of Bax (Additional file 5: Figure S1F).
MiR‑106b enhances tumour‑initiating cell capacity 
without or with IR
A colony sphere formation assay was performed to 
explore the effect of miR-106b on the tumour-initiating 
cell capacity. The data indicated that the ability of cells 
to form colony spheres was dramatically enhanced, as 
indicated by more numerous and larger spheres in cells 
that expressed increased levels of miR-106b. Conversely, 
decreasing the expression of miR-106b decreased the 
ability of cells to form colony spheres (**p<0.01; Fig. 2a). 
In addition, the expression levels stemness-related genes 
and proteins were detected by qRT-PCR and western 
blot. The levels of CD133, Sox2, Oct4 and Bmi1 were 
increased at the RNA level (*p<0.05; Fig.  2b). However, 
only CD133 and Sox2 were up-regulated at the protein 
level after the overexpression of miR-106b in SW620 cells 
(Additional file  6: Figure  S2). The results were further 
confirmed by miR-106b knockdown in SW480 cells.
The acquisition of tumour-initiating cell capacity has 
been reported to be associated with tumour radioresist-
ance. Therefore, we investigated the potential relation-
ship between the tumour-initiating cell capacity and CRC 
radioresistance. The data indicated that SW620 cells that 
overexpressed miR-106b more readily formed colony 
spheres, which was accompanied by increased CD133 
and Sox2 protein levels, while the inhibition of miR-106b 
in SW480 cells yielded the opposite effect (**p<0.01; 
Fig. 2c, d). However, the expression of Oct4 and Bmi1 did 
not show significantly alter the protein levels (data not 
shown).
In conclusion, cells that express high levels of miR-
106b more strongly initiated tumours under both nor-
mal and IR conditions. This finding may explain why cells 
that express higher high levels of endogenous miR-106b 
exhibit greater proliferation potential and resistance to 
IR.
MiR‑106b targets PTEN and p21 for repression
We focused on the targets of miR-106b and found via a 
bioinformatics search in Targetscan (http://www.tar-
getscan.org) that the 3′-UTRs of human PTEN and p21 
contained regions that matched the seed sequences of 
miR-106b (Fig. 3a). PTEN is an important negative regu-
lator of PI3K-AKT signalling that is involved in the com-
plex response to IR via the induction of cell cycle arrest in 
the G2/M phase and apoptosis [21, 22]. CDKN1A (p21), a 
key inhibitor of the cell cycle, is also frequently dysfunc-
tional in human cancer [23]. Increasing the endogenous 
miR-106b levels by either oligonucleotide transfection 
(*p<0.05; Additional file 7: Figure S3A) or lentiviral trans-
duction could significantly decrease PTEN expression 
both at the RNA and protein levels, but the expression of 
P21 was only decreased at the protein level. The inhibi-
tion of miR-106b yielded the same effect (Fig. 3b, c).
To verify whether PTEN is a direct target of miR-106b, 
PTEN 3′-UTR, the sequence that contains the miR-106b 
binding sites, was cloned into the downstream luciferase 
open reading frame. The co-transfection of miR-106b 
mimics and the PTEN-3′-UTR-wild vector into SW620 
cells (pLuc-PTEN-3′-UTR) significantly decreased the 
luciferase activity compared with miR-NC mimics. In 
contrast, the transfection of miR-106b inhibitors into 
SW480 increased the luciferase activity. However, the 
transfection of mimics or inhibitors of miR-106b with the 
mutant 3′-UTR vector (pLuc-PTEN-mut 3′-UTR) did not 
affect the luciferase activity (Fig. 3d).
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We also successfully constructed a reporter vector that 
includes the p21 3′UTR-wild vector (pLuc- p21- 3′UTR). 
The co-transfection of miR-106b mimics and the p21-
3′UTR -wild vector into SW620 cells (pLuc-p21-3′UTR) 
significantly decreased the luciferase activity compared with 
miR-NC mimics. In contrast, the transfection of miR-106b 
inhibitors into SW480 significantly increased the luciferase 
activity (**p<0.01; Fig.  3e). The results further confirmed 
that PTEN and p21 are direct targets of miR-106b.
MiR‑106b mediated‑radioresistance can be reversed 
by activating PTEN/PI3K/AKT and p21 pathway
PTEN is an important negative regulator of PI3K/AKT 
signalling [24]. Our studies found that the overexpres-
sion of miR-106b improves p-AKT1/2 expression, and 
miR-106b knockdown could inhibit the expression of 
p-AKT1/2 (Fig. 4a).
We sought to determine whether the restoration of 
PTEN in miR-106b-overexpressing SW620 cells could 
reduce the cell resistance to IR. A pcDNA3.1/PTEN 
vector that expressed the PTEN gene was constructed 
and successfully transfected into miR-106b-overex-
pressing SW620 cells, and the success of this transfec-
tion was verified with a western blot (Additional file  7: 
Figure 3B). MTT assays showed that restoring the PTEN 
expression by transfecting the pcDNA3.1/PTEN vector 
enhanced the cell sensitivity to IR (**p<0.01; Fig. 4b). The 
immunofluorescence results also confirmed that the res-
toration of PTEN could significantly increase the number 
of γ-H2AX foci (**p<0.01, *p<0.05; Fig. 4c).
Additionally, the transfection of PTEN siRNA into 
miR-106b-knockdown SW40 cells (Additional file 7: Fig-
ure  S3C) could induce cell resistance to IR, which was 
confirmed by MTT assays and immunofluorescence 
staining (*p<0.05, **p<0.01; Fig. 4b, c).
p21 is recognized to play a role in the protection of 
cancer cells from stress and DNA damage [25]. Our find-
ings indicated that p21 was also a direct target of miR-
106b. Thus, we sought to identify the role of p21 in cell 
radioresistance in the presence of miR-106b.
First, p21 was knocked down by transfecting siRNA 
into SW620 (Additional file  7: Figure  S3D the left), and 
the cells were then exposed to irradiation (4  Gy). The 
result suggested that p21 knockdown could increase 
the number of γ-H2AX foci (**p<0.01; Additional file 7: 
Figure  S3E) and the expression of γ-H2AX (Additional 
file  7: Figure  S3F). Overall, we showed that p21 func-
tioned as an irradiation resistance factor, which was con-
sistent with previous studies. We then transfected the 
pcDNA3.1/p21 vector into miR-106b-overexpressing 
SW620 cells (Additional file 7: Figure S3D the right). We 
found that the number of γ-H2AX foci (*p<0.05; Fig. 4d) 
and γ-H2AX protein level were higher than those of the 
control group (Additional file 7: Figure S3G).
Fig. 2 MiR-106b enhances tumour-initiating cell capacity without or with IR. a miR-106b induces stem cell-like self-renewal properties. The 
sphere sizes are shown in the left panels, and the numbers of spheres are shown in the right panels. Scale bars represent 50 mm. **p<0.01. b Genes 
important for stem cell maintenance, such as CD133, Sox2, oct4 and bmi1, were analysed with a qRT-PCR array. *p<0.05. c The ability of colorectal 
cancer (CRC) cell lines after exposure to radiation to form colon spheres was analysed. Sphere sizes are shown in the left panels, and the numbers 
of spheres are shown in the right panels. Scale bars represent 50 mm. **p<0.01. d Genes important for stem cell maintenance, i.e., CD133 and Sox2, 
were analysed by western blot after irradiation (4 Gy).
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Next, we transfected siRNA/p21 into SW480-anti-miR-
106b cells in order to determine whether reducing the 
expression of p21 in SW480-anti-miR-106b cells could 
restore the cell radioresistance potential. The γ-H2AX 
foci numbers did not significantly change compared with 
the control, which indicated that p21 knockdown did not 
affect the radioresistance under PTEN/PI3K/AKT path-
way activation conditions (data not shown).
Finally, we treated miR-106b-overexpressing SW620 
cells with LY294002, which is a highly selective inhibi-
tor of Akt, and the cells were then irradiated (4 Gy). The 
data showed that blocking the PTEN/PI3K/AKT pathway 
could enhance the cell sensitivity to IR (*p<0.05; Addi-
tional file 7: Figure S3H).
Based on these data, we concluded that the PTEN/
PI3K/AKT pathway plays a dominant role in miR-106b 
mediated-radioresistance in CRC.
MiR‑106b is inversely correlated with PTEN expression 
in colorectal cancer
We found an inverse correlation between miR-106b RNA 
expression and PTEN protein expression in colorec-
tal cancer cell lines of different differentiation degrees 
(Fig.  5a). PTEN is one of the most frequent tumour 
Fig. 3 PTEN and p21 are targets of miR-106b. a PTEN and p21 3′UTRs contain predicted miR-106b binding sites. In the figure the alignment of the 
seed regions of miR-106b with PTEN and p21 3′UTRs is shown. b The expression levels of PTEN and p21 after the inhibition of miR-106b via lentiviral 
transduction in SW480 cells or the overexpression of the same miRNA by oligonucleotide transfection or lentiviral transduction in SW620 cells were 
detected using western blot. c The mRNA expression levels of PTEN after the inhibition of miR-106b in SW480 cells or the overexpression of the 
same miRNA in SW620 cells was detected using qRT-PCR. **p<0.01. d PTEN 3′UTRs are targets of miR-106b. pluc3-PTEN that contained a wild-
type or mutated PTEN 3′UTRs (indicated as WT or mut on the X-axis) was transfected into SW620 or SW480 cells. The relative repression of firefly 
luciferase was standardized to a transfection control. The reporter assays were performed three times with essentially identical results. **p<0.01. 
e p21 3′UTRs are targets of miR-106b. pluc3-p21 that contained a wild-type p21 3′UTRs was transfected into SW620 or SW480 cells. The relative 
repression of firefly luciferase was standardized to a transfection control. The reporter assays were performed three times with essentially identical 
results.**p<0.01.
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suppressors in human cancers [26, 27], and miR-106b is 
upregulated in colorectal cancer tissues. Thus, we evalu-
ated the endogenous levels of miR-106b and PTEN using 
real-time quantitative RT-PCR (qRT-PCR) in primary 
colorectal cancer tissues (Additional file 8: Figure S4). We 
found that the expression levels of miR-106b and PTEN 
significantly correlated in colorectal tissues (p  =  0.006, 
Spearman’s r  =  −0.491) (Fig.  5b). The results showed 
Fig. 4 MiR-106b mediating-radioresistance can be rescued by PTEN/PI3K-AKT and p21 pathway. a p-AKT1/2 levels were examined by western blot 
after miR-106b overexpression or downregulation. b The detection of cell sensitivity to radiation (4 Gy) by MTT 4 days after co-transfection with 
mir-106b and pcDNA3.1/PTEN or anti-miR-106b and siRNA/PTEN. **p<0.01. c γ-H2AX was examined by immunofluorescence in the SW620 cells 
co-transfected with miR-106b and pcDNA3.1/PTEN or SW480 co-transfected with anti-miR-106b and siRNA/PTEN when exposed to radiation (4 Gy, 
6 h). The γ-H2AX staining is shown in the left panels, and the numbers of γ-H2AX foci are shown in the right panels. **p<0.01, *p<0.05. d γ-H2AX was 
examined by immunofluorescence after co-transfection with mir-106b and pcDNA3.1/p21 in SW620 cells when exposed to radiation (4 Gy, 6 h). The 
γ-H2AX staining is shown in the left panels and the numbers of γ-H2AX foci are shown in the right panels. *p<0.05.
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that the expression of miR-106b inversely correlated with 
PTEN in colorectal cancer and normal colonic tissues, 
which further supported the finding that PTEN is a direct 
target of miR-106b in vivo.
Discussion
Wang et  al. previously demonstrated with a microarray 
that miR-106b was upregulated in colon cancer cases 
with lymph node metastasis [28]. Although miR-106b is 
clearly dysregulated in many human cancers, including 
CRC [29, 30], few studies are available on its roles on can-
cer radiosensitivity, especially in CRC.
Highly differentiated adenocarcinoma is commonly 
more resistant to irradiation than poorly differentiated 
adenocarcinoma. HT-29 and SW480 are known as highly 
differentiated cell lines with high levels of endogenous 
miR-106b. The expression of this miR-106b is low in the 
SW620 cell line, which is poorly differentiated. Therefore, 
we selected the SW620 and SW480 cell lines for the sub-
sequent gain and loss of function studies, respectively. 
The overexpression of miR-106b could inhibit cell apop-
tosis, promote proliferation and induce radioresistance 
in  vitro and in  vivo when cells were irradiated, which 
revealed that miR-106b may be an anti-apoptotic and 
DNA damage repair factor in the presence of radiation.
p21 is a well-known tumour suppressor that func-
tions by mediating G1 growth arrest and cellular senes-
cence [31], and previous studies also revealed that p21 
knockdown was closely related to metastasis and poor 
survival in CRC [32, 33]. We have verified that p21 is a 
direct target of miR-106b, as confirmed by a bioinformat-
ics search and a luciferase assay. We also found that miR-
106b could induce G1 to S transition (Additional file  9: 
Figure S5), which is a radioresistant cell cycle phase [34]. 
In summary, p21 may play an important role in the miR-
106b-mediated G1 to S transition and radioresistance, 
which may also explain why cells that express high levels 
of endogenous miR-106b are highly resistant to IR.
Previous studies of different tumours confirmed that 
p21 is closely linked to a favourable prognosis [31, 33]. 
However, p21 protects cells from death following anti-
cancer treatments, including exposure to radiation, 
which has been confirmed over the past 30 years [22, 35, 
36]. Based on these previous studies, the function of p21 
Fig. 5 PTEN expression is inversely related to that of miR-106b 
in colorectal cancer. a A western blot for the PTEN protein was 
performed in colorectal cancer cell lines. b qRT-PCR on 15 colorectal 
cancer patients. The association between miR-106b and PTEN mRNA 
for the 15 subjects in the tumour class and for the paired 15 subjects 
in the normal class was statistically calculated using the Spearman 
correlation coefficient (p = 0.006, Spearman’s r = −0.491). The Spear-
man correlation indicated an inverse relation between miR-106b and 
PTEN mRNA in the normal and tumour samples.
Fig. 6 MiR-106b enhances radioresistance by targeting PTEN and 
p21. miR-106b upregulation downregulates PTEN and p21 and subse-
quently enhances radioresistance. p21 functioned as a DNA damage 
repair promoter at “a relatively normal level” of miR-106b and PI3K/
AKT, while it acted as a DNA damage repair inhibitor when altering 
miR-106b expression.
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appears to be pleiotropic. Our results determined that at 
a “relatively normal level” of miR-106b cells (such as that 
in wild type cells, like SW620), p21 knockdown could 
enhance cell sensitivity to IR, which indicated that p21 
functioned as a DNA damage repair factor. This result 
was consistent with those of previous studies. However, 
we also found that p21 functioned as a DNA damage 
factor, not a repair factor, when the expression of miR-
106b was up- or downregulated. The overexpression 
of p21 in miR-106b-overexpressing SW620 cells could 
reverse the miR-106b-mediated radioresistance, which 
suggested that p21 functioned as a DNA damage repair 
inhibitor. We verified that p21 had little function in DNA 
damage repair at high levels of miR-106b and activated 
PI3K-AKT conditions; inversely, it induced growth arrest 
and senescence and functioned as a DNA damage repair 
inhibitor.
Thus, we inferred that p21 played dual roles in the 
DNA damage repair process, as a promoter or inhibitor, 
and this role depended on its cellular context. Moreover, 
miR-106b may be one of the important factors that affect 
this role. Priority should be given to block p21 in order 
to promote DNA damage repair. This approach allows us 
to more effectively utilize p21 as a therapeutic target that 
preferentially preserves its tumour suppressive functions, 
such as growth arrest.
Our research elucidated that miR-106b could enhance 
the cell self-renew capacity and upregulate the expres-
sion of stem cell markers under both normal and radia-
tion conditions. Previous studies have shown that both 
normal and cancer stem cells are chemoresistant and 
radioresistant [37]. We provide a direct link between the 
self-renewal capacity and radioresistance, which may 
partially explain why the overexpression of miR-106b 
could induce cell radioresistance. p21 played dual roles 
in stem cells; for example, basal p21 expression levels 
maintain stem cells quiescence, while increasing p21 
expression promotes cells differentiation and limits the 
self-renewal potential [34]. When miR-106b increases 
the capacity of cells to initiate tumours, increased p21 
expression promotes cell differentiation and limits self-
renewal potential, which may partially explain why p21 
minimally impacts the repair of DNA damage caused by 
miR-106b.
By integrating a bioinformatics search (Targetscan) 
and luciferase assay, we identified PTEN as another func-
tional direct target of miR-106b. Studies have shown that 
PTEN plays an important role in both the early and late 
stages of CRC and PTEN loss positively correlated with 
malignant progression, such as tumour size and the TNM 
advanced stage [38]. Recent studies showed that the res-
toration of PTEN could decrease the ratio of metastases 
in an orthotopic model of colon cancer [39].
We demonstrated that the induction of miR-106b 
expression could produce a radioresistant phenotype 
in the normally radiosensitive SW620 cells, while the 
restoration of PTEN could partially reverse this effect. 
Similarly, PTEN knockdown could restore the radiore-
sistance of SW480, which may have been due to miR-
106b downregulation. To the best of our knowledge, 
PTEN is a natural inhibitor of PI3K at the 3-phosphate 
site and negatively regulates the AKT signalling pathway 
[40]. We proved that miR-106b could positively regulate 
p-AKT expression by downregulating PTEN. Blocking 
the PI3K/AKT pathway by using LY294002 could reverse 
the miR-106b-mediated radioresistance. Based on the 
above results, we concluded that miR-106b enhanced the 
cell resistance to IR via PTEN/PI3K/AKT pathway.
Dubrovska et  al. found that the PTEN/PI3K/Akt 
pathways are critical for prostate cancer stem-like cell 
maintenance and that targeting PI3K signalling may be 
beneficial in prostate cancer treatment by eliminating 
prostate cancer stem-like cells [41]. However, we found 
that p21 and PTEN indirectly interact with CD133 or 
sox2. Thus, we hypothesise that p21 and PTEN interact 
with CD133 or sox2 via some other genes or signalling 
pathways.
The PI3K-AKT pathway can undoubtedly be activated 
by miR-106b via the direct targeting of PTEN. The res-
toration of p21 and PTEN expression or treatment with 
a PI3K-AKT pathway inhibitor can reverse miR-106b-in-
duced radioresistance. However, p21 knockdown in 
SW480- anti-miR-106b cells did not induce significant 
radiosensitivity changes, which indicated that p21 down-
regulation insufficiently reversed the radiosensitivity and 
did not ameliorate the DNA damage status, unless the 
PTEN/PI3K-AKT pathway was activated by miR-106b 
knockdown. We speculated that p21 is a point of internal 
contact and interaction between two genes and that the 
PTEN/PI3K-AKT pathway plays a dominant role during 
p21 function transformation and miR-106b-mediated cell 
radioresistance in CRC.
To further assess the relationship between PTEN and 
miR-106b, we screened the PTEN expression in CRC cell 
lines as well as clinical specimens. Our data indicated 
that HT29 and SW480 cells, which express higher levels 
of endogenous miR-106b and have been verified as radi-
oresistant [42], expressed less PTEN than the more radi-
osensitive cell lines SW620 and LOVO cells. The clinical 
specimens also revealed that elevated levels of miR-106b 
correlated with low PTEN expression, indicating miR-
106b may be a causal factor for PTEN loss in CRC.
Conclusion
In this study, we identified miR-106b could induce cell 
radioresistance by targeting p21, which induces G1/S 
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transition and restrains apoptosis and activating the 
PTEN/PI3K-AKT pathway. Moreover, this process was 
accompanied by an enhancement of the tumour-initiat-
ing cell capacity, suggesting that miR-106b may account 
for the resistance to radiotherapy and may be a potential 
clinical therapeutic target for patients who rarely benefit 
from radiation therapy in CRC (Fig. 6).
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Additional file 1: Table S1. Primers for quantification.
Additional file 2: Construction of PTEN and p21 vectors and 
transfection.
Additional file 3: miR-106b overexpression  or knockdown amounts of 
miR-106b were established via lentiviral transduction.
Additional file 4: Construction of luciferase reporter vectors.
Additional file 5: MiR-106b induces CRC cell resistance to irradiation. 
Figure S1.  (A) The expression pattern of miR-106b in CRC cell lines with 
different degrees of differentiation. The relative expression of miR-106b 
was normalized to the endogenous control U6. (B) The up-regulation 
or inhibition of miR-106b in SW620 via lentiviral transduction in SW480 
cells was detected using qRT-PCR. *p<0.05. (C) γ-H2AX was examined by 
immunofluorescence in the HT-29 cells transfected with miR-106b when 
exposed to radiation (4 Gy, 6 h). The γ-H2AX staining is shown in the left 
panels, and the numbers ofγ-H2AX foci are shown in the right panels. 
*p<0.05. (D) Apoptosis as evaluated by flow cytometry when exposed to 
radiation (4 Gy). **P<0.005, **P<0.01. (E) Photographs of tumours from 
mice injected with cells. (F) The expression of Bcl-2 and Bax in xenograft 
tumours exposed to radiation was detected by immunohistochemistry.
Additional file 6: Detection of stemness-related markers. Figure S2.  
Genes important for stem cell maintenance, i.e., CD133 and Sox2, 
were examined by western blot after miR-106b overexpression or 
downregulation.
Additional file 7: MiR-106b mediated-radioresistance can be reversed 
by activating PTEN/PI3K/AKT and p21 pathway. Figure S3. (A) The mRNA 
expression levels of miR-106b in SW620 cells after the forced expression 
of miR-106b by oligonucleotide transfection was detected using qRT-PCR 
*p<0.05. (B) and (C) PTEN protein expression in SW480 cells co-transfected 
with miR-106b and pcDNA3.1/PTEN in SW620 or co-transfected with 
anti-miR-106b and siRNA/PTEN. (D) The p21 protein expression was 
examined by western blot in SW620 cells transfected with siRNA/p21 
or co-transfected with miR-106b and pcDNA3.1/p21. (E) γ-H2AX was 
examined by immunofluorescence after transfection with siRNA/p21 
in SW620 cells. The γ-H2AX staining is shown in the left panels, and the 
numbers of γ-H2AX foci are shown in the right panels. **p<0.01. (F) The 
γ-H2AX protein expression was examined by western blot in SW620 
cells transfected with siRNA/P21. (G) The γ-H2AX protein expression was 
examined by western blot in SW620 cells co-transfected with miR-106b 
and pcDNA3.1/p21. (H) γ-H2AX was examined by immunofluorescence 
in the SW620-miR-106b cells treated with LY294002. The γ-H2AX staining 
is shown in the left panels, and the numbers of γ-H2AX foci are shown in 
the right panels. *p<0.05.
Additional file 8: qRT-PCR of samples from 15 colorectal cancer 
patients. Figure S4. The expression of miR-106b and PTEN mRNA was 
detected by qRT-PCR in the 15 subjects from the tumour group and the 
15 paired normal controls.
Additional file 9: MiR-106b promotes G1 to S transition. Figure S5. 
Comparison of G1/S fractions after miR-106b overexpression in SW620 
cells or downregulation in SW480 cells by flow cytometry. The percentage 
of cells in the G1 and S phases and the statistic analysis are shown in the 
right panel. **p<0.01.
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